Total Liabilities Equity - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.584 EUR -1.33%
Market Cap: 217.3m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanobiotix SA
Total Liabilities & Equity Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Total Liabilities & Equity
€93.9m
CAGR 3-Years
-11%
CAGR 5-Years
15%
CAGR 10-Years
29%
Valneva SE
PAR:VLA
Total Liabilities & Equity
€466.6m
CAGR 3-Years
-14%
CAGR 5-Years
13%
CAGR 10-Years
7%
Innate Pharma SA
PAR:IPH
Total Liabilities & Equity
€151.5m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
4%
Genfit SA
NASDAQ:GNFT
Total Liabilities & Equity
€173.9m
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
20%
Eurobio Scientific SA
PAR:ALERS
Total Liabilities & Equity
€316.3m
CAGR 3-Years
22%
CAGR 5-Years
35%
CAGR 10-Years
25%
OSE Immunotherapeutics SA
PAR:OSE
Total Liabilities & Equity
€82.1m
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Total Liabilities & Equity?
Total Liabilities & Equity
93.9m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Total Liabilities & Equity amounts to 93.9m EUR.

What is Nanobiotix SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
29%

Over the last year, the Total Liabilities & Equity growth was 57%. The average annual Total Liabilities & Equity growth rates for Nanobiotix SA have been -11% over the past three years , 15% over the past five years , and 29% over the past ten years .

Back to Top